US2022333069A1PendingUtilityA1
Three dimensional heterogeneously differentiated tissue culture
Assignee: IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBHPriority: Dec 13, 2012Filed: May 2, 2022Published: Oct 20, 2022
Est. expiryDec 13, 2032(~6.4 yrs left)· nominal 20-yr term from priority
C12N 2506/45C12N 5/0619C12N 2506/02C12N 2501/727C12N 2501/385C12N 2500/44C12N 2501/33C12N 2533/90C12N 2501/91G01N 33/5058C12N 5/0697C12N 2513/00C12N 5/0696C12N 2501/115
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides an artificial tissue culture comprising a heterogeneous population of cells of at least two different tissue sections, wherein said tissue sections are in a three dimensional structure, method of generating such a tissue and kits suitable for said method or maintain a three dimensional tissue culture.
Claims
exact text as granted — not AI-modified1 . An in vitro grown artificial Three-dimensional neuronal tissue culture comprising a heterogeneous population of cells of at least two different progenitor and neuronal differentiation layers, wherein at least on progenitor layer comprises outer radial glia cell.
2 . Tissue culture according to claim 1 , wherein said tissue sections form at least two layers, preferably at least one layer being shaped around a globular tissue body.
3 . Tissue culture according to claim 1 or 2 , wherein said tissue develops apical and dorsal tissue sections.
4 . Tissue culture according to any one of claims 1 to 3 , wherein said tissue is cerebral tissue.
5 . Tissue culture according to any one of claims 1 to 4 , wherein cells of said culture express one or more gene expression markers selected from forebrain markers BF1 and Six3, hindbrain markers Krox20 and Ils1, preferably wherein forebrain markers are expressed in increased amounts as compared to hindbrain markers.
5 . Tissue culture according to any one of claims 1 to 5 , wherein cells of said culture express one or more gene expression markers selected from Otx1, Otx2, FoxG1, Auts2, Tuj1, Brn2, Satb2, Ctip2, calretinin.
7 . A method of generating an artificial tissue culture comprising providing a multicellular aggregation of pluripotent stem cells culturing said multicellular aggregation in a three dimensional matrix, preferably a gel, thereby expanding said cells in a multicellular aggregation, wherein said cells are allowed to differentiate, and culturing said expanded and optionally differentiated multicellular aggregation of cells in a suspension culture.
8 . The method of claim 7 , wherein said pluripotent cell an induced pluripotent cell, especially an induced pluripotent cell that has been isolated from a patient.
9 . The method of claim 7 or 8 , wherein said expanded cells differentiate into unipotent stem cells.
10 . The method of any one of claims 7 to 8 , wherein the three dimensional matrix comprises collagen or an extracellular matrix from the Engelbreth-Holm-Swarm tumor, or any component thereof selected from laminin, collagen, entactin, and heparan-sulfated proteoglycan or any combination thereof.
11 . The method of investigating a developmental neurological tissue effect comprising decreasing or increasing the expression in a gene of interest in a cell at any stage during the method of any one of claims 7 to 10 .
12 . The method of screening a candidate therapeutic agent suitable for treating a developmental neurological tissue detect of interest, comprising performing the method of claim 11 and administering the candidate agent to said cells at any stage during the method, preferably at all stages.
13 . The method of testing a candidate drug for neurological effects, comprising administering a candidate drug to an artificial culture according to any one of claims 1 to 6 and determining an activity of interest of the cells of said culture and comparing said activity to an activity of cells to the culture without administering said candidate drug, wherein a differential activity indicates a neurological effect.
14 . The method of obtaining a differentiated neural cell comprising the step of providing an artificial culture according to any one of claims 1 to 6 and isolating a differentiated neural cell of interest, or comprising the step of generating an artificial tissue culture according to any one of claims 7 to 10 further comprising the step of isolating a differentiated neural cell of interest.
15 . A kit for generating an artificial three-dimensional neuronal tissue culture according to any one of claims 1 to 6 or for performing the method of any one of claims 7 to 14 comprising a medium comprising a three dimensional matrix and nutrients and a medium comprising retinoic acid and nutrients, optionally further comprising a medium comprising nutrients and a ROCK inhibitor and/or optionally comprising a medium comprising nutrients but lacking growth factors that would differentiate neural tissue to a particular fate.Join the waitlist — get patent alerts
Track US2022333069A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.